Clincosm LogoSign in Get a demo

cd20 positive

Showing 1 - 10 of 10
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

CD20 Positive, Mantle Cell Lymphoma Trial in United States (procedure, other, biological)

Recruiting
  • CD20 Positive
  • Mantle Cell Lymphoma
  • Autologous Hematopoietic Stem Cell Transplantation
  • +2 more
  • Birmingham, Alabama
  • +318 more
Jan 3, 2023

Blastoid Variant Mantle Cell Lymphoma, CCND1 Protein Overexpression, CD20 Positive Trial in Houston (Acalabrutinib, Venetoclax)

Recruiting
  • Blastoid Variant Mantle Cell Lymphoma
  • +8 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 5, 2022

Blastoid Variant Mantle Cell Lymphoma, CD20 Positive, Mantle Cell Lymphoma Trial in Houston (drug, other, biological)

Active, not recruiting
  • Blastoid Variant Mantle Cell Lymphoma
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Mar 8, 2022

Ann Arbor Stage II Follicular Lymphoma, Ann Arbor Stage II Marginal Zone Lymphoma, Ann Arbor Stage III Follicular Lymphoma Trial

Active, not recruiting
  • Ann Arbor Stage II Follicular Lymphoma
  • +9 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 3, 2022

CCND1 Positive, CCND2 Positive, CCND3 Positive Trial in Houston (drug, other, biological)

Active, not recruiting
  • CCND1 Positive
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 11, 2022

CD20 Positive, Recurrent DLBCL, Refractory DLBCL Trial in Buffalo (drug, other, biological)

Active, not recruiting
Has Results
  • CD20 Positive
  • +6 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Oct 11, 2021

Acute Lymphoblastic Leukemia, Adult Acute Lymphoblastic Leukemia in Complete Remission, Burkitt Leukemia Trial in Houston (drug,

Completed
Has Results
  • Acute Lymphoblastic Leukemia
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Apr 6, 2021

CD20 Positive, Chronic Lymphocytic Leukemia, Follicular Lymphoma Trial in Houston (procedure, biological, drug)

Completed
  • CD20 Positive
  • +6 more
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +7 more
  • Houston, Texas
    M D Anderson Cancer Center
May 30, 2019

CD20 Positive, Recurrent B-Cell Non-Hodgkin Lymphoma, Refractory B-Cell Non-Hodgkin Lymphoma Trial in United States (Ipilimumab,

Completed
  • CD20 Positive
  • +2 more
  • Ipilimumab
  • +2 more
  • Duarte, California
  • +6 more
Apr 10, 2018

CD20 Positive, Recurrent DLBCL, Refractory DLBCL Trial in New York (drug, other, biological)

Completed
  • CD20 Positive
  • +2 more
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Jan 25, 2018